Back

Nephro-protective effects of Dapagliflozin in patients with type 2 diabetes

27 August 2016 (11:40 - 11:50)
Organised by:
Congress Presentation Part of: Improving diabetes outcomes: beyond glucocentricity Diabetes management ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Masafumi Nakayama

Tokyo D Tower Hospital, Tokyo (Japan)

7 More presentations in this session

Presentation thumbnail
Excess risk of heart failure among persons with type 2 diabetes
Professor A. Rosengren (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of didpeptidyl peptidase 4 inhibitors and sodium-glucose linked cotransporter-2 inhibitors in patients with type 2 diabetes mellitus: a meta-analysis
Doctor G. Savarese (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Impact of pioglitazone on cardiovascular events in patients with type-II diabetes mellitus after drug-eluting stent implantation
Doctor H. Yokoi (Fukuoka, JP)
Abstract Slides Video
Presentation thumbnail
Histone 3 lysine 27 trimethylation in type 2 diabetes: a novel potential pharmacological target in diabetic foot ulcer treatment
Doctor M. Colognesi-Capogrossi (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Impact of the presence and treatment status of diabetes on long-term mortality following coronary angiography
Doctor B. Zafrir (Haifa, IL)
Abstract Slides Video

Access the full session

Session thumbnail
Improving diabetes outcomes: beyond glucocentricity

The Event

Event poster

ESC Congress 2016

27 August 2016 11:40 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources